Symptom duration and resolution with early outpatient treatment of convalescent plasma for COVID- 19: a randomized trial

By sjmartinez • February 2, 2023

Baksh S, Heath SL, Fukuta Y, Shade D, Meisenberg B, Bloch EM, Tobian AAR, Spivak ES, Patel B, Gerber J, Raval JS, Forthal D, Paxton J, Mosnaim G, Anjan S, Blair J, Cachay E, Currier J, Das P, Huaman M, Sutcliffe C, Yarava A, Casadevall A, Sullivan D, Hanley D, Gebo KA; CSSC-004 Consortium. Symptom duration and resolution with early outpatient treatment of convalescent plasma for COVID- 19: a randomized trial. J Infect Dis. 2023 Jan 31:jiad023. doi: 10.1093/infdis/jiad023. Epub ahead of print. PMID: 36722044.

Tags: covid-19, COVID-19 serotherapy, Infectious Diseases, plasma, Publications, Symptom duration

Sexual network characteristics, condomless anal intercourse, and the HIV care cascade among MSM living with controlled versus uncontrolled HIV infection in Lima, Peru: a population-based cross-sectional analysis

Harris CL, Blair CS, Segura ER, Gutiérrez J, Lake JE, Cabello R, Clark JL. Sexual network characteristics, condomless anal intercourse, and the HIV care cascade[...]

Associations of U.S. state-level COVID-19 policies intensity with cannabis sharing behaviors in 2020

Assaf RD, Hamad R, Javanbakht M, Arah OA, Shoptaw SJ, Cooper ZD, Gorbach PM. Associations of U.S. state-level COVID-19 policies intensity with cannabis sharing behaviors[...]

GM-CSF receptor expression determines opposing innate memory phenotypes at different stages of myelopoiesis

Guerrero P, Bono C, Sobén M, Guiu A, Cheng QJ, Gil ML, Yáñez A. GM-CSF receptor expression determines opposing innate memory phenotypes at different stages[...]